ImmunoGen’s $175 Million Term Loan Financing

Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors.ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan financing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here